Gene Query: NDUFV3

Dataset Description Geneva Score
The effect of Abl kinases on non-small cell carcinoma global transcriptome 32.44
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 28.15
STX4 Over-Expression in Human islets 27.52
Characterization of the Merkel cell carcinoma miRNome 27.46
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 27.3
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 25.82
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 21.72
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 21.44
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 19.2
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 17.45
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 17.41
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 16.96
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 16.85
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 15.92
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 15.32
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 15.32
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 15.0
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 15.0
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 14.98
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 13.5
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 13.33
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 13.29
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 12.82
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 12.64
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 12.64
RNA-seq of MCF10A cells and CAF 12.49
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.42
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 11.86
MCF-7 as a model for functional analysis of breast cancer risk variants 11.78
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 11.46
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 11.25
RIG-I and MDA5 fRIP during KSHV lytic reactivation 11.1
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 11.06
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 11.05
A20 regulates canonical wnt-signaling through an interaction with RIPK4 10.91
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 10.8
SLAM-seq for K562 endogenous mRNA decay 10.74
RNA polymerase in pre-B-ALL cell lines 10.71
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 10.69
Molecular Mechanisms of Endothelial Hyperpermeability 10.66
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.54
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 10.46
Mitochondrial dsRNA triggers antiviral signalling in humans 10.28
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.21
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.18
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.13
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.94
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 9.68
A prostate cancer chromatin interaction map 9.63
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 9.49
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.45
Direct Isolation and Characterization of Human Nephron Progenitors. 9.34
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 9.21
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 9.21
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 9.06
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 8.95
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 8.87
Control of prostate tumour growth by the long non-coding RNA GHSROS 8.83
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 8.81
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.35
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 8.31
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 8.27
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.22
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 8.21
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 8.21
Capturing the Interactome of Newly Transcribed RNA (RICK) 8.15
Capturing the Interactome of Newly Transcribed RNA 8.15
Global analysis of enhancer targets: Mosaic-seq 8.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.91
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.8
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.8
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.63
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 7.62
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 7.61
RNA m5C Methylation in breast cancer using MeRIP-Seq 7.56
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 7.56
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 7.42
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 7.38
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.37
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.37
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.35
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.33
Role of microRNAs in the interaction between Salmonella and the host cell 7.29
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 7.18
Lipid degradation promotes prostate cancer cell survival 7.17
CROP-Seq in Primary Human T Cells 7.11
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.1
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 7.03
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.02
Human neutrophil genome during PMA- and E. coli encounter-induced activation 7.02
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 7.02
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 7.0
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.98
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 6.97
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 6.92
The evolution of N6-methyladenosine in primates 6.86
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.86
Regulatory network controlling tumor-promoting inflammation in human cancers 6.84
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 6.84
Human HAP1 cells before and after nutrient deprivation 6.8
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.8
scRNASeq analysis of cycling cardiomyocytes 6.8
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 6.69
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 6.59
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.59
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.58
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.58
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 6.55
Effect of BMP inhibition or stimulation of primary human keratinocytes 6.55
Aortic Valve Tissue: Stenosis vs. Sclerosis 6.55
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.53
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.52
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 6.49
Alteration of the microRNA network during the progression of Alzheimer’s disease 6.44
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 6.43
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 6.43
Regulation of highly expressed hCINAP on translatome 6.43
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 6.42
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.42
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.4
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.39
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.37
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.37
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 6.35
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 6.28
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.27
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.27
High-throughput sequencing of PROMPT-enriched samples. 6.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.25
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.25
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 6.12
Single-cell analysis of human kidney organoids 6.06
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.01
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.99
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.96
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.94
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.87
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.86
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.86
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 5.86
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 5.86
Identification of renal resident macrophages across species 5.8
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.78
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 5.76
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 5.76
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.67
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.66
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.65
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.64
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.64
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.54
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.43
Patient-derived luminal breast cancer xenografts with progestins 5.43
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 5.42
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 5.36
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.33
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 5.3
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 5.3
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.29
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.27
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 5.26
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.23
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.22
MYC dependent mRNA translation shapes gene expression and cell biology 5.22
RNA-seq of IL-4 stimulated human keratinocytes 5.17
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 5.14
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.09
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 5.07
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.07
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.06
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 5.05
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 5.05
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.02
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.02
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.97
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.94
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 4.93
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.91
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 4.91
Argonaute proteins couple chromatin silencing to alternative splicing 4.88
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 4.88
Next generation sequencing of small RNAs isolated from exosomes in human semen 4.81
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.79
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 4.79
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.74
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.74
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.72
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.66
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.63
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 4.63
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.63
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 4.62
SNHG5 siRNA knock down in HCT116 cells 4.61
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.61
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 4.61
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.59
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 4.54
T47D RNA-seq and ChrRNA-seq data 4.53
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.53
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.52
Gene expression in GBM with Cav3.2 inhibition 4.5
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.49
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 4.47
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 4.46
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.43
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 4.41
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.41
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.41
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.39
Gene expression changes caused by KRAS in MCF-10A 4.38
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 4.37
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 4.31
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.22
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.2
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.18
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.17
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.12
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 4.12
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 4.08
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.07
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.06
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.05
mRNA-Seq profiling of human developing kidney 4.03
Identification of HOXB13 target genes responsive to BET inhibitors 4.0
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.97
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.96
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 3.96
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.93
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.9
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 3.89
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.84
BASP1 modifies the Tamoxifen response 3.84
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.8
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.73
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.73
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.72
Transcriptome analysis of kidney organoids 3.71
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.67
Transcriptome analysis of CNS leukemia 3.61
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.61
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.59
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.59
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 3.55
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.54
Transcriptomic profile of human embryonic renal corpuscles 3.43
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.38
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.37
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 3.36
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.36
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.36
RNA-seq melanoma 3.31
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.25
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.24
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.24
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.22
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.22
Loss of CREBBP results in gene expression repression in lymphoma cells 3.22
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 3.22
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 3.19
DRB/GRO-Seq -/+ UV 3.17
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.16
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.13
TFAP2C signalling in human fibroblasts 3.12
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.1
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 3.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 3.09
quanTIseq: quantifying immune contexture of human tumors 3.03
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.01
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.97
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.93
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.93
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.93
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.92
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.9
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.9
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.88
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 2.88
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.88
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.87
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.85
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.85
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.83
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.8
Genome-wide discovery of human splicing branchpoints 2.74
RNA sequencing of primary human platelets and in vitro cell lines 2.72
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 2.72
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.66
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 2.6
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.58
Triple vectors expand AAV transfer capacity in the retina 2.56
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.55
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 2.54
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.51
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.51
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.5
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.5
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.34
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.34
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.29
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.28
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 2.27
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.26
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.26
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 2.25
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.25
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.22
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.21
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.21
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.2
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.18
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.15
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.11
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.06
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.05
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.05
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.02
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.0
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.97
MicroRNA-125a-5p overexpression in human macrophages 1.95
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 1.94
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.92
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.92
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.9
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.9
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.9
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.88
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.85
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.84
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.83
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.81
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.8
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 1.8
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.79
NAPRT activation of macrophages 1.78
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.74
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.74
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.71
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.69
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.68
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.68
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.68
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.67
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.65
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.63
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.62
Role of cervicovaginal microbiota in genital inflammation 1.61
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.6
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.6
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.59
Genome-wide discovery of human splicing branchpoints [RNAse] 1.57
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 1.56
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.56
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.56
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.55
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.54
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.53
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.53
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.52
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.47
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.47
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.46
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.46
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.45
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 1.43
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.41
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.41
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.41
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 1.37
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 1.36
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.33
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.32
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.28
6mer seed toxicity in tumour suppressive microRNAs 1.27
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.23
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.22
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.22
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.21
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.2
hESC neural differentiation 1.2
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.19
WRN knockout effects upon gene expression in SW48 and OVK18 1.18
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.15
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.06
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.02
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.01
IMP3 regulated gene expression in breast cancer cells 0.99
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.97
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.91
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.91
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.9
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.9
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.9
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.89
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.89
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.89
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.87
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.87
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.86
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.83
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.83
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.82
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.81
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 0.81
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.78
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.78
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 0.77
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.75
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.75
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.72
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.69
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.69
Transcriptome of EBV-infected gastric cancer cell lines 0.64
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.63
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.62
Transcriptomic analysis of human macrophages in 3D 0.61
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.6
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.59
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.57
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.57
Transcriptome-wide response to synthetic chromatin protein PcTF 0.57
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.55
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.51
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.51
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.51
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.49
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.49
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.49
Identification of global XBP1s target gene expression in human prostate cancer cells 0.48
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.48
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.47
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.47
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.47
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.46
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 0.45
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.45
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.45
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 0.43
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 0.43
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.41
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.4
Deep RNA sequencing of the human placental transcriptome 0.4
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.38
Transcriptional responses of melanoma cells to BRAF inhibition 0.37
A single-cell transcriptome atlas of the human pancreas 0.36
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.35
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.33
RNA-Seq and expression data from human adipose tissue 0.33
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.33
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.33
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.32
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.31
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.3
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.29
RNA-seq data 0.28
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 0.27
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.27
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.25
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.24
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.24
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.21
Genome-wide analysis of the Integrator complex 0.21
Genome-wide analysis of the Integrator complex (HTS) 0.21
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.2
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.19
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.19
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.15
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.15
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.15
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.14
miR-93 Targets in Human Endothelial Cells 0.13
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.13
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.12
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.12
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 0.12
MARS Seq data from human cortical organoids 0.11
The transcriptome of Kawasaki Disease arteritis 0.11
Iron response of HepG2 cells 0.09
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.08
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.07
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.06
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.05
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.05
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.05
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.05
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.04
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.02
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.02
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation